Fifth Lane Capital’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Fifth Lane Capital’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,000	Closed	-$304K	–	249
2022 Q4	$304K	Buy	+15,000	New	+$230K	0.27%	55

Fifth Lane Capital's OPNT Position: Q1 2023 in Review

Fifth Lane Capital sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 15,000 shares — an estimated $304K sold.

Fifth Lane Capital first reported a position in OPNT in Q4 2022 and held it in 1 quarter. The position peaked at $304K in Q4 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

Fifth Lane Capital reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Fifth Lane Capital sold 15,000 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $304K.
Fifth Lane Capital first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Fifth Lane Capital's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $304K in Q4 2022.
0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Fifth Lane Capital's 13F filing for Q1 2023, filed 15 May 2023.